Evotec SE

EVO Nasdaq SEC CIK 1412558
Follow Evotec Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2024 EUR · IFRS
Revenue, last year €797M +2% vs prior year
Net income −€196.1M −133.7% vs prior year
EPS, diluted −€1.11 −136.2% vs prior year
Operating cash flow €18.2M −50% vs prior year
Revenue by fiscal year
€446.4M
€500.9M
€618M
€751.4M
€781.4M
€797M
FY19 FY20 FY21 FY22 FY23 FY24

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−€250M€0€250M€500M€750M€1BFY18FY19FY20FY21FY22FY23FY24
Show the numbers
YearRevenueNet income
FY24€797M−€196.1M
FY23€781.4M−€83.9M
FY22€751.4M−€175.7M
FY21€618M€215.5M
FY20€500.9M€6.3M
FY19€446.4M€38.2M
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−40%−20%0%20%40%FY18FY19FY20FY21FY22FY23FY24
Show the numbers
YearGross marginOperating marginNet margin
FY2414.4%−17.9%−24.6%
FY2322.4%−6.1%−10.7%
FY2223.2%2.8%−23.4%
FY2124.5%6.6%34.9%
FY2025.1%9.7%1.3%
FY1929.8%14%8.5%
FY18---
Free cash flowOperating cash flow minus capital expenditure
−€200M−€100M€0€100MFY18FY19FY20FY21FY22FY23FY24
Show the numbers
YearFree cash flow
FY24−€99.2M
FY23−€176.9M
FY22€24.5M
FY21€7.7M
FY20−€54.4M
FY19€10.9M
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Evotec
  • Healthcare median
−100%−50%0%50%FY18FY19FY20FY21FY22FY23FY24
Show the numbers
YearEvotecHealthcare median
FY24−24.6%−47%
FY23−10.7%−58%
FY22−23.4%−80.4%
FY2134.9%−71.8%
FY201.3%−62.2%
FY198.5%−46.2%
FY18-−49.6%